Welcome to our Medical & Research Programs Section. Here you will find details of all our latest Programs.
|
|
Friday, 03 August 2012 10:56 |
|
The Alpha One Foundation is part of the Rare Disease Taskforce. The Rare Disease Taskforce is acting as a catalyst for the development of better health care services for people with a rare disease in Ireland. It aims to highlight key developments in relation to rare diseases in Ireland and the EU context and to communicate issues related to the forthcoming National Plan for Rare Diseases in Ireland. Rare Disease Day 2012
February 29th, 2012 marked the Fifth International Rare Disease Day. On this day hundreds of patient organisations from more than 50 countries worldwide organised awareness-raising activities converging around the slogan "Rare But Strong Together".
Eurordis launched a specially produced promotional video highlighting Rare Disease Day in Europe. The video was made in Dublin and featured real people affected by rare conditions.
Six people from Ireland, each with a different rare condition, featured in the video. The message is simple – It’s not unusual to have a rare condition. Look out for us and you’ll see how many we are!
To tie in with the video, GRDO created a postcard campaign to highlight Rare Disease Day in Ireland. Each postcard featured a character from the video and a short message about Rare Disease Day. The postcards were delivered to politicians and other public figures, as well as to media representatives across Ireland. An "Easy Guide" has been produced to increase awareness about the challenges of living with a rare disease and to highlight the priorities that need to be included in the forthcoming National Plan for Rare Diseases (NPRD) in Ireland. The aims of this "Easy Guide" are to:
• Explain what a rare disease is
• Highlight the challenge of living with a rare disease in Ireland
• Highlight priorities that should be included in the National Plan for Rare Diseases in Ireland |
|
|
Monday, 13 December 2010 10:23 |
|
The Alpha One Foundation invites research proposals applications for consideration in the Medical Research Charities Group (MRCG) and Health Research Board (HRB) joint funding scheme 2011. This joint funding scheme has been in operation since 2006 and provides funding of up to €100,000 per annum for clearly defined research projects for up to 36 months. Smaller projects are also considered. For further information about applying for the joint funding scheme please contact Kitty O'Connor by email
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or by phone on 01-8093871. Deadlines for submissions of applications is 5pm Friday the 21st of January 2011. |
|
Monday, 24 November 2008 12:54 |
Craig Thelwell1, Peter Rigsby2 and Colin Longstaff1 1Biotherapeutics Group, Haemostasis Section and 2Biostatistics Division, National Institute for Biological Standards and Control, South Mimms, Herts EN6 3QG, UK |
|
Read more...
|
|
Monday, 24 November 2008 12:52 |
|
Author - T. CARROLL, O. FLOYD, C. O’CONNOR, J. McPARTLIN, C. TAGGART, R. COSTELLO, S. J. O’NEILL and N. G. McELVANEY Institution – Department of Respiratory Research, RCSI Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland. Rationale: AAT deficiency is a hereditary autosomal codominant disorder, resulting from mutations in the AAT gene, and classically presents with emphysema and liver disease. The most common phenotype presenting with clinical evidence of AAT deficiency is the Z phenotype, resulting in decreased levels of circulating AAT due to retention of the aberrantly folded protein in the liver. It is unclear whether the carrier status confers increased risk for disease. Demographic studies indicate that AAT deficiency is under-diagnosed and prolonged delays in diagnosis are common. World Health Organisation guidelines advocate targeted detection programmes of patients with COPD and asthma. |
|
Read more...
|
Conference Abstracts: American Thoracic Society Annual Conference 2008. Title – Evidence for the Activation of the Unfolded Protein Response (UPR) in Monocytes from Alpha-1 Antitrypsin Deficient Individuals |
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
|
Page 1 of 3 |